Moxalactam therapy of haemophilus influenzae type b meningitis in children
- 1 March 1984
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 104 (3) , 454-459
- https://doi.org/10.1016/s0022-3476(84)81116-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDRENThe Lancet, 1983
- Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and childrenAntimicrobial Agents and Chemotherapy, 1982
- Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitisThe Journal of Pediatrics, 1982
- Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitisThe Journal of Pediatrics, 1981
- Oral chloramphenicol in the treatment of Haemophilus influenzae meningitisThe Journal of Pediatrics, 1981
- Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitisThe Journal of Pediatrics, 1981
- Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infantsThe Journal of Pediatrics, 1981
- Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicolThe Journal of Pediatrics, 1980
- In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporinsAntimicrobial Agents and Chemotherapy, 1980
- In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillinAntimicrobial Agents and Chemotherapy, 1980